Detecting repeated cancer evolution from multi-region tumor sequencing data.

Nature Methods
Giulio CaravagnaAndrea Sottoriva

Abstract

Recurrent successions of genomic changes, both within and between patients, reflect repeated evolutionary processes that are valuable for the anticipation of cancer progression. Multi-region sequencing allows the temporal order of some genomic changes in a tumor to be inferred, but the robust identification of repeated evolution across patients remains a challenge. We developed a machine-learning method based on transfer learning that allowed us to overcome the stochastic effects of cancer evolution and noise in data and identified hidden evolutionary patterns in cancer cohorts. When applied to multi-region sequencing datasets from lung, breast, renal, and colorectal cancer (768 samples from 178 patients), our method detected repeated evolutionary trajectories in subgroups of patients, which were reproduced in single-sample cohorts (n = 2,935). Our method provides a means of classifying patients on the basis of how their tumor evolved, with implications for the anticipation of disease progression.

References

Jun 1, 1990·Cell·E R Fearon, B Vogelstein
Nov 14, 2007·PLoS Computational Biology·Niko BeerenwinkelMartin A Nowak
Mar 10, 2009·International Journal of Cancer. Journal International Du Cancer·Swapnali PathareManoj Mahimkar
Sep 25, 2010·Proceedings of the National Academy of Sciences of the United States of America·Camille Stephan-Otto AttoliniFranziska Michor
Dec 14, 2011·Gut·Richard F A LoganUNKNOWN English Bowel Cancer Screening Evaluation Committee
Jan 20, 2012·Nature·Mel Greaves, Carlo C Maley
Feb 24, 2012·The New England Journal of Medicine·Ann G ZauberJerome D Waye
Mar 9, 2012·The New England Journal of Medicine·Marco GerlingerCharles Swanton
May 1, 2012·Nature Biotechnology·Scott L CarterGad Getz
May 23, 2012·Cell·Serena Nik-ZainalUNKNOWN Breast Cancer Working Group of the International Cancer Genome Consortium
Sep 11, 2012·Nature·UNKNOWN Cancer Genome Atlas Research Network
Sep 25, 2012·Nature·UNKNOWN Cancer Genome Atlas Network
Feb 16, 2013·Proceedings of the National Academy of Sciences of the United States of America·Andrea SottorivaSimon Tavaré
Sep 21, 2013·Nature·Rebecca A BurrellCharles Swanton
Mar 19, 2014·Nature Methods·Andrew RothSohrab P Shah
Aug 1, 2014·Nature·UNKNOWN Cancer Genome Atlas Research Network
Aug 28, 2014·Genome Biology·Davide PrandiFrancesca Demichelis
Oct 10, 2014·PloS One·Loes Olde LoohuisBud Mishra
Jan 15, 2015·Cancer Cell·Nicholas McGranahan, Charles Swanton
Jun 23, 2015·Nature Medicine·Lucy R YatesPeter J Campbell
Sep 17, 2015·Cancer Cell·Jinkuk KimDo-Hyun Nam
Mar 8, 2016·Trends in Cancer·Kamil A LipinskiMarco Gerlinger
May 28, 2016·Genome Biology·Alexander Davis, Nicholas E Navin
Jul 1, 2016·Proceedings of the National Academy of Sciences of the United States of America·Giulio CaravagnaBud Mishra
Jul 29, 2016·Cell Systems·Mohammed El-KebirBenjamin J Raphael
Oct 16, 2016·The Journal of Pathology·Trevor A Graham, Andrea Sottoriva
Feb 12, 2017·Cell·Nicholas McGranahan, Charles Swanton
Feb 14, 2017·Nature Reviews. Genetics·Russell Schwartz, Alejandro A Schäffer
Apr 27, 2017·The New England Journal of Medicine·Mariam Jamal-HanjaniUNKNOWN TRACERx Consortium
Sep 28, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H X DangC A Maher

❮ Previous
Next ❯

Citations

Feb 28, 2019·Breast Cancer Research and Treatment·F AfzaliM Gardaneh
Mar 29, 2019·Nature Reviews. Genetics·Samra TurajlicCharles Swanton
Aug 3, 2019·PLoS Computational Biology·Ramon Diaz-Uriarte, Claudia Vasallo
Jul 10, 2019·Cell Death and Differentiation·Keefe T ChanRichard B Pearson
Apr 29, 2020·Nature Reviews. Cancer·Matthew A Clarke, Jasmin Fisher
Jul 14, 2020·Bioinformatics·Ermin HodzicS Cenk Sahinalp
Sep 3, 2020·International Journal of Cancer. Journal International Du Cancer·Yong ZhangYun Xiao
Mar 31, 2019·Genome Medicine·Matthew W Fittall, Peter Van Loo
Feb 7, 2020·Nature Communications·Yulia RubanovaUNKNOWN PCAWG Consortium
Jun 18, 2020·Frontiers in Bioengineering and Biotechnology·Fabrizio AngaroniMarco Antoniotti
Sep 13, 2019·Bioinformatics·Sayed-Rzgar HosseiniNiko Beerenwinkel
Sep 13, 2019·Bioinformatics·Sahand KhakabimamaghaniMartin Ester
Feb 11, 2020·Frontiers in Oncology·Jonathan R Goodman, Hutan Ashrafian
Sep 30, 2020·Nature Genetics·Marco MinaGiovanni Ciriello
May 7, 2019·Annual Review of Genomics and Human Genetics·Marc J WilliamsTrevor A Graham
Nov 12, 2019·PLoS Computational Biology·Sahand KhakabimamaghaniMartin Ester
Oct 29, 2020·JCO Clinical Cancer Informatics·James W T Yates, Hitesh Mistry
Jan 23, 2021·International Journal of Molecular Sciences·Alina FinchColin Watts
Jan 1, 2021·Bioinformatics·Sarah ChristensenMohammed El-Kebir
Feb 27, 2021·Journal of Digital Imaging·Hongtao ChenShaolin Li
Mar 21, 2021·Nature Communications·Min ZhangDean A Fennell
Apr 8, 2021·Nature Communications·Jeffrey WestAlexander R A Anderson
May 1, 2021·International Journal of Molecular Sciences·Antonio Jesús Banegas-LunaHoracio Pérez-Sánchez
Oct 15, 2021·Bioinformatics·Fabrizio AngaroniDaniele Ramazotti
Aug 28, 2021·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Stefano ScaleraMarcello Maugeri-Saccà
Dec 22, 2021·PLoS Computational Biology·Juan Diaz-Colunga, Ramon Diaz-Uriarte
Jan 22, 2022·Clinical and Translational Medicine·Xiaoqian LiuZhiyong Liang

❮ Previous
Next ❯

Methods Mentioned

BETA
single-cell sequencing

Software Mentioned

IntClust
ClonEvol
mathop
REVOLVER

Related Concepts

Related Feeds

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Related Papers

American Journal of Clinical Pathology
Omar Hameed, John D Pfeifer
Nursing Mirror
J Iveson-Iveson
Nature Genetics
Christopher J Ricketts, W Marston Linehan
© 2022 Meta ULC. All rights reserved